Open Demat Account

Morepen Laboratories -MOREPENLAB Share Price

Sector: Pharmaceuticals

₹ 49.65

-0.65 (-1.29%)

CMPMay 03,2024 12:00 AM

Trade in Morepen Laboratories with IIFl Securities! Trade Now

Performance

Morepen Laboratories LTD KEY RATIOS

sector: Pharmaceuticals

  • CMP

    -

    -
  • Open
  • ₹ 50.60
  • Prev. Close
  • ₹ 50.30
  • Turnover(Lac.)
  • ₹ 1,018
  • Day's High
  • ₹ 50.65
  • Day's Low
  • ₹ 49.20
  • 52 Week's High
  • ₹ 56.40
  • 52 Week's Low
  • ₹ 25.10
  • Book Value
  • ₹ 17
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 2,538
  • P/E
  • 31.26
  • EPS
  • 1.59
  • Divi. Yield
  • 0

Morepen Laboratories LTD PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr. View All Peer Comparison

MORE ABOUT MOREPEN LABORATORIES LTD

Summary

Morepen Laboratories Limited is an India-based pharmaceutical company. Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin. The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-DT, Acifix, Rabipen- DSR and Montelast. It has new products added to the therapeutic categories, including Kilbac, Ducal D, Aclomore and Montelast-L.The company has three state-of-the-art manufacturing plants in the northern state of Himachal Pradesh (HP) in India. The main plant at Parwanoo is inspected and approved by United States Food and Drug Administration (USFDA) for production of Loratadine Read More


Reports by Morepen Laboratories LTD


Reports by Morepen Laboratories LTD

x